Back to Trades
Grant4
DEXCOM INC
DXCM
Total Value
$194.6K
Company Information
- Company Name
- DEXCOM INC
- Ticker Symbol
- DXCM
- CIK
- 0001093557
Insider Information
- Name
- Sylvain Jereme M
- Role
- EVP, Chief Financal Officer
- Location
- SAN DIEGO, CA
Officer
Filing Details
- Filing Date
- Feb 2, 2026
- Transaction Date
- Jan 29, 2026
- Accession Number
- 0001093557-26-000011
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | 7,123 | — | Grant/Award | — |
| Jan 29, 2026 | Common Stock | 2,652 | $73.36 | Tax Withholding | $194.6K |
Footnotes
- (F1)Represents shares issued to the Reporting Person upon vesting of performance-based restricted stock units (PSUs) granted to the Reporting Person on March 8, 2023, resulting from achievement of performance conditions under the PSUs.
- (F2)Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person.
- (F3)Included in this number are 83,328 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 7,256 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 79 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.